News $3 Million Funds Research to Develop New HIV Vaccine StrategiesSep 24, 2015Infectious disease researchers at the University of Rochester School of Medicine and Dentistry will use $3.1 million from the National Institutes of Health to find new ways to develop a vaccine to prevent HIV, the virus that causes AIDS. URMC Start-up Takes Aim at Memory and Cognitive Problems Apr 30, 2015A new start-up company built around research conducted at the School of Medicine and Dentistry plans to attack the memory and cognitive problems that often plague patients with neurodegenerative diseases like multiple sclerosis and Parkinson’s disease. University of Rochester Medical Center Honors Satcher Award RecipientsApr 30, 2015The community health improvement awards distinguish individuals who have made significant contributions to community health in the greater Rochester region through research, education, clinical services and outreach efforts.UR Tests HIV Vaccine Pill Jan 13, 2015Researchers at the University of Rochester Medical Center are testing a new oral vaccine to prevent infection with HIV, the virus that causes AIDS. The vaccine is unique because it is given as a pill, unlike most HIV vaccines tested to date that have been given as shots. Researchers Receive $3.4 million to Study Experimental Drug Combination in HIV Aug 28, 2014Researchers at the University of Rochester Medical Center and University of Nebraska Medical Center have received a $3.4 million grant from the National Institutes of Health to study an experimental drug combination that appears to rid white blood cells of HIV and keep the infection in check for long periods. While current HIV treatments involve pills that are taken daily, the experimental drugs’ long-lasting effects suggest the possibility of an HIV treatment that could be administered monthly, or perhaps a few times a year.